Financial Synergies Wealth Advisors, Inc. Amphastar Pharmaceuticals, Inc. Transaction History
Financial Synergies Wealth Advisors, Inc.
- $742 Billion
- Q2 2024
Shares
1 transactions
Others Institutions Holding AMPH
# of Institutions
279Shares Held
33.4MCall Options Held
56.6KPut Options Held
57.3K-
Black Rock Inc. New York, NY6.08MShares$258 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.73MShares$116 Million0.0% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA2.08MShares$88.2 Million0.21% of portfolio
-
Neuberger Berman Group LLC New York, NY1.66MShares$70.5 Million0.06% of portfolio
-
State Street Corp Boston, MA1.51MShares$64.3 Million0.0% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $2.08B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...